BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 24631102)

  • 1. Infectious outcomes of nephrostomy drainage before percutaneous nephrolithotomy compared to concurrent access.
    Benson AD; Juliano TM; Miller NL
    J Urol; 2014 Sep; 192(3):770-4. PubMed ID: 24631102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures.
    Korets R; Graversen JA; Kates M; Mues AC; Gupta M
    J Urol; 2011 Nov; 186(5):1899-903. PubMed ID: 21944106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of routine stone culture in percutaneous nephrolithotomy--a prospective study.
    Margel D; Ehrlich Y; Brown N; Lask D; Livne PM; Lifshitz DA
    Urology; 2006 Jan; 67(1):26-9. PubMed ID: 16413326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study.
    Gravas S; Montanari E; Geavlete P; Onal B; Skolarikos A; Pearle M; Sun YH; de la Rosette J
    J Urol; 2012 Sep; 188(3):843-7. PubMed ID: 22819398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study.
    Walton-Diaz A; Vinay JI; Barahona J; Daels P; González M; Hidalgo JP; Palma C; Díaz P; Domenech A; Valenzuela R; Marchant F
    Int Urol Nephrol; 2017 Jan; 49(1):31-35. PubMed ID: 27848063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Percutaneous Nephrolithotomy in Moderate to High Infectious Risk Population: A Report from the EDGE Consortium.
    Sur RL; Krambeck AE; Large T; Bechis SK; Friedlander DF; Monga M; Hsi RS; Miller NL; Chew BH; Lange D; Knudsen B; Sourial MW; Humphreys MR; Stern KL; Shah O; Abbott JE; Abedi G
    J Urol; 2021 May; 205(5):1379-1386. PubMed ID: 33369488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy.
    Lojanapiwat B; Kitirattrakarn P
    Urol Int; 2011; 86(4):448-52. PubMed ID: 21508617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stone culture retrieved during percutaneous nephrolithotomy: is it clinically relevant?
    Osman Y; Elshal AM; Elawdy MM; Omar H; Gaber A; Elsawy E; El-Nahas AR
    Urolithiasis; 2016 Aug; 44(4):327-32. PubMed ID: 26781741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study.
    Mariappan P; Smith G; Bariol SV; Moussa SA; Tolley DA
    J Urol; 2005 May; 173(5):1610-4. PubMed ID: 15821509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous nephrolithotomy in the pediatric population.
    Al-Shammari AM; Al-Otaibi K; Leonard MP; Hosking DH
    J Urol; 1999 Nov; 162(5):1721-4. PubMed ID: 10524922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous nephrolithotomy success in the transplant kidney.
    Krambeck AE; Leroy AJ; Patterson DE; Gettman MT
    J Urol; 2008 Dec; 180(6):2545-9. PubMed ID: 18930500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
    Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
    J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Controlled Comparison of Nephrostomy Drainage vs Ureteral Stent Following Percutaneous Nephrolithotomy Using the Wisconsin StoneQOL.
    Zhao PT; Hoenig DM; Smith AD; Okeke Z
    J Endourol; 2016 Dec; 30(12):1275-1284. PubMed ID: 27736198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine flexible nephroscopy for percutaneous nephrolithotomy for renal stones with low density: a prospective, randomized study.
    Gücük A; Kemahlı E; Üyetürk U; Tuygun C; Yıldız M; Metin A
    J Urol; 2013 Jul; 190(1):144-8. PubMed ID: 23313202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and Postoperative Predictors of Infection-Related Complications in Patients Undergoing Percutaneous Nephrolithotomy.
    Rivera M; Viers B; Cockerill P; Agarwal D; Mehta R; Krambeck A
    J Endourol; 2016 Sep; 30(9):982-6. PubMed ID: 27393153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infundibular stenosis after percutaneous nephrolithotomy.
    Parsons JK; Jarrett TW; Lancini V; Kavoussi LR
    J Urol; 2002 Jan; 167(1):35-8. PubMed ID: 11743270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistant bacteriuria before percutaneous nephrolithotomy predicts for postoperative infectious complications.
    Patel N; Shi W; Liss M; Raheem O; Wenzler D; Schallhorn C; Kiyama L; Lakin C; Ritter M; Sur RL
    J Endourol; 2015 May; 29(5):531-6. PubMed ID: 25424241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of preoperative neutrophil-lymphocyte count ratio on predicting postoperative sepsis after percutaneous nephrolithotomy.
    Sen V; Bozkurt IH; Aydogdu O; Yonguc T; Yarimoglu S; Sen P; Koras O; Degirmenci T
    Kaohsiung J Med Sci; 2016 Oct; 32(10):507-513. PubMed ID: 27742034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical analysis of supracostal access for percutaneous renal surgery.
    Munver R; Delvecchio FC; Newman GE; Preminger GM
    J Urol; 2001 Oct; 166(4):1242-6. PubMed ID: 11547050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Midstream Urine Cultures
    Liu M; Chen J; Gao M; Zeng H; Cui Y; Zhu Z; Chen H
    J Endourol; 2021 Oct; 35(10):1467-1478. PubMed ID: 34128382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.